PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
31481513-5	2019	Western blot, gene expression, and proliferation assays were performed in various AR-positive enzalutamide-sensitive and -resistant prostate cancer cell lines.	enzalutamide	94-106	androgen receptor	Rattus norvegicus	82-84	
27590197-0	2017	Absorption, Distribution, Metabolism, and Excretion of the Androgen Receptor Inhibitor Enzalutamide in Rats and Dogs.	enzalutamide	87-99	androgen receptor	Rattus norvegicus	59-76	
27590197-1	2017	BACKGROUND AND OBJECTIVES: Enzalutamide is an androgen receptor inhibitor that has been approved in several countries.	enzalutamide	27-39	androgen receptor	Rattus norvegicus	46-63	
34610715-0	2021	Influence of Androgen Receptor Antagonist MDV3100 Therapy on Rats With Benign Prostatic Hyperplasia.	enzalutamide	42-49	androgen receptor	Rattus norvegicus	13-30	
34610715-1	2021	PURPOSE: To probe the effect and mechanism of androgen receptor antagonist MDV3100 on benign prostatic hyperplasia (BPH) of rats.	enzalutamide	75-82	androgen receptor	Rattus norvegicus	46-63	
34610715-13	2021	CONCLUSION: Androgen receptor antagonist MDV3100 alleviates BPH and inflammatory response through miR-21-3p downregulation and NF-kappaB signaling pathway blockade.	enzalutamide	41-48	androgen receptor	Rattus norvegicus	12-29